| |
|
NASH | Abstract Library |
 |
| |
| The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors. |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 13. | Incidence and Impact of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients with Adenocarcinoma of the Esophagus Treated with Curative Intent |
| |
World J Surg. 2022 Oct 20. doi: 10.1007/s00268-022-06781-w. Online ahead of print.
John V Reynolds 1, Noel E Donlon 2, Jessie A Elliott 2, Brendan Moran 2, Hugo Temperley 2, Tim S Nugent 2, Maria Davern 2, Sinead King 2, Melissa Conroy 2, Joanne Lysaght 2, Narayanasamy Ravi 2, Carmel Ryan 3, Stephen Finn 3, Suzanne Norris 4, Clare L Donohoe 2
|
|
| |
| 14. | Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles |
| |
Hepatology. 2022 Oct;76(4):1121-1134. doi: 10.1002/hep.32427. Epub 2022 Mar 17.
Ibon Martínez-Arranz 1, Chiara Bruzzone 2, Mazen Noureddin 3, Ruben Gil-Redondo 2, Itziar Mincholé 1, Maider Bizkarguenaga 2, Enara Arretxe 1, Marta Iruarrizaga-Lejarreta 1, David Fernández-Ramos 2, Fernando Lopitz-Otsoa 2, Rebeca Mayo 1, Nieves Embade 2, Elizabeth Newberry 4, Bettina Mittendorf 5, Laura Izquierdo-Sánchez 6, Vaclav Smid 7, Jorge Arnold 8, Paula Iruzubieta 9, Ylenia Pérez Castaño 10, Marcin Krawczyk 11 12, Urko M Marigorta 2, Martine C Morrison 13, Robert Kleemann 13, Antonio Martín-Duce 14, Liat Hayardeny 15, Libor Vitek 7, Radan Bruha 7, Rocío Aller de la Fuente 16, Javier Crespo 9, Manuel Romero-Gomez 17, Jesus M Banales 6 18, Marco Arrese 8 19, Kenneth Cusi 20, Elisabetta Bugianesi 21, Samuel Klein 5, Shelly C Lu 3, Quentin M Anstee 22 23, Oscar Millet 2, Nicholas O Davidson 4, Cristina Alonso 1, José M Mato 2
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 28. | Effect of pharmacological interventions and placebo on liver Histology in nonalcoholic steatohepatitis: A network meta-analysis |
| |
Nutr Metab Cardiovasc Dis. 2022 Oct;32(10):2279-2288.doi: 10.1016/j.numecd.2022.07.001. Epub 2022 Jul 16.
Grazia Pennisi 1, Ciro Celsa 1, Marco Enea 2, Marco Vaccaro 2, Vito Di Marco 1, Carlo Ciccioli 1, Giuseppe Infantino 1, Claudia La Mantia 1, Stefanie Parisi 1, Federica Vernuccio 3, Antonio Craxì 1, Calogero Cammà 1, Salvatore Petta 4
|
|
| |
|
|
| |
| 30. | The Impact of Bariatric-Surgery-Induced Weight Loss on Patients Undergoing Liver Transplant: A Focus on Metabolism, Pathophysiological Changes, and Outcome in Obese Patients Suffering NAFLD-Related Cirrhosis |
| |
J Clin Med. 2022 Sep 8;11(18):5293. doi: 10.3390/jcm11185293.
Gerardo Sarno 1, Luigi Schiavo 2 3, Pietro Calabrese 2 3, Ludwig Álvarez Córdova 4, Evelyn Frias-Toral 5 6, Gabriela Cucalón 7, Eloisa Garcia-Velasquez 8, Vanessa Fuchs-Tarlovsky 9, Vincenzo Pilone 2 3
|
|
| |
|
|
| |
| 32. | Combination Treatment with Hydroxytyrosol and Vitamin E Improves NAFLD-Related Fibrosis |
| |
Nutrients. 2022 Sep 14;14(18):3791.
Nadia Panera 1, Maria Rita Braghini 1, Annalisa Crudele 1, Antonella Smeriglio 2, Marzia Bianchi 1, Angelo Giuseppe Condorelli 3, Rebecca Nobili 3, Libenzio Adrian Conti 4, Cristiano De Stefanis 4, Gessica Lioci 5, Fabio Gurrado 5, Donatella Comparcola 6, Antonella Mosca 6, Maria Rita Sartorelli 6, Vittorio Scoppola 1, Gianluca Svegliati-Baroni 7 8, Domenico Trombetta 2, Anna Alisi 1
|
|
| |
|
|
| |
| 34. | Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes |
| |
Diabetes Metab. 2022 Sep;48(5):101363. doi: 10.1016/j.diabet.2022.101363. Epub 2022 Jun 24.
Erminia Lembo 1, Maria Francesca Russo 1, Ornella Verrastro 1, Danila Anello 1, Giulia Angelini 1, Amerigo Iaconelli 1, Caterina Guidone 1, Gianluigi Stefanizzi 1, Luigi Ciccoritti 1, Francesco Greco 1, Luca Sessa 1, Laura Riccardi 1, Maurizio Pompili 1, Marco Raffaelli 1, Fabio Maria Vecchio 1, Stefan R Bornstein 2, Geltrude Mingrone 3, Amalia Gastaldelli 4, Esmeralda Capristo 1
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 47. | Disease State Transition Probabilities Across the Spectrum of NAFLD: A Systematic Review and Meta-Analysis of Paired Biopsy or Imaging Studies |
| |
Clin Gastroenterol Hepatol. 2022 Aug 4;S1542-3565(22)00733-9.doi: 10.1016/j.cgh.2022.07.033. Online ahead of print.
Phuc Le 1, Julia Yang Payne 2, Lu Zhang 3, Abhishek Deshpande 4, Michael B Rothberg 4, Naim Alkhouri 5, William Herman 6, Adrian V Hernandez 7, Mary Schleicher 8, Wen Ye 9, Srinivasan Dasarathy 10
|
|
| |
| 48. | Metabolic Injury of Hepatocytes Promotes Progression of NAFLD and AALD |
| |
Semin Liver Dis. 2022 Aug;42(3):233-249. doi: 10.1055/s-0042-1755316.Epub 2022 Aug 24.
Raquel Carvalho-Gontijo # 1 2, Cuijuan Han # 1 2, Lei Zhang 1 2, Vivian Zhang 1 2, Mojgan Hosseini 3, Kristin Mekeel 2, Bernd Schnabl 1, Rohit Loomba 1, Michael Karin 4, David A Brenner 1, Tatiana Kisseleva 2
|
|
| |
| 49. | Obeticholic Acid Impact on Quality of Life in Patients With Nonalcoholic Steatohepatitis: REGENERATE 18-Month Interim Analysis |
| |
Clin Gastroenterol Hepatol. 2022 Sep;20(9):2050-2058.e12.doi: 10.1016/j.cgh.2021.07.020. Epub 2021 Jul 15.
Zobair M Younossi 1, Maria Stepanova 2, Fatema Nader 2, Rohit Loomba 3, Quentin M Anstee 4, Vlad Ratziu 5, Stephen Harrison 6, Arun J Sanyal 7, Jörn M Schattenberg 8, A Sidney Barritt 9, Mazen Noureddin 10, Martin Bonacci 11, Gail Cawkwell 11, Bruce Wong 11, Mary Rinella 12, RandomizEd Global Phase 3 Study to Evaluate the Impact on NASH with FibRosis of Obeticholic Acid TreatmEnt (REGENERATE) Study Investigators
|
|
| |
| 50. | Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial |
| |
J Hepatol. 2022 Sep;77(3):607-618.doi: 10.1016/j.jhep.2022.04.003.Epub 2022 Apr 16.
Naim Alkhouri 1, Robert Herring 2, Heidi Kabler 3, Zeid Kayali 4, Tarek Hassanein 5, Anita Kohli 6, Ryan S Huss 7, Yanni Zhu 7, Andrew N Billin 7, Lars Holm Damgaard 8, Kristine Buchholtz 8, Mette Skalshøi Kjær 8, Clare Balendran 8, Robert P Myers 7, Rohit Loomba 9, Mazen Noureddin 10
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 54. | Dynamic Changes in Ultrasound Quality for Hepatocellular Carcinoma Screening in Patients With Cirrhosis |
| |
Clin Gastroenterol Hepatol. 2022 Jul;20(7):1561-1569.e4. doi: 10.1016/j.cgh.2021.06.012.Epub 2021 Jun 10.
Haley Schoenberger 1, Nicolas Chong 1, David T Fetzer 2, Nicole E Rich 1, Takeshi Yokoo 2, Gaurav Khatri 2, Jocelyn Olivares 3, Neehar D Parikh 4, Adam C Yopp 5, Jorge A Marrero 3, Amit G Singal 6
|
|
| |
| 55. | Elevated de novo lipogenesis, slow liver triglyceride turnover, and clinical correlations in nonalcoholic steatohepatitis patients |
| |
J Lipid Res. 2022 Jul 11;63(9):100250. doi: 10.1016/j.jlr.2022.100250. Online ahead of print.
Eric J Lawitz 1, Kelvin W Li 2, Edna Nyangau 2, Tyler John Field 2, Jen-Chieh Chuang 3, Andrew Billin 3, Lulu Wang 3, Ya Wang 3, Ryan S Huss 3, Chuhan Chung 3, G Mani Subramanian 3, Robert P Myers 3, Marc K Hellerstein 4
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 60. | NASH Presence is Associated with a Lower Weight Loss One and 2 Years After Bariatric Surgery in Women with Severe Obesity |
| |
Obes Surg. 2022 Jul 6. doi: 10.1007/s11695-022-06175-w. Online ahead of print.
Fàtima Sabench # 1 2, Laia Bertran # 2, Margarita Vives 1, Marta París 1, Carmen Aguilar 2, Salomé Martínez 2, Jessica Binetti 2 3, Monica Real 3, Alja Alibalic 3, Cristóbal Richart 2, Daniel Del Castillo 1 2, Teresa Auguet 4 5
|
|
| |
|
|
| |
|
|
| |
| 63. | Direct Comparison of Quantitative US versus Controlled Attenuation Parameter for Liver Fat Assessment Using MRI Proton Density Fat Fraction as the Reference Standard in Patients Suspected of Having NAFLD |
| |
Radiology. 2022 Jul;304(1):75-82. doi: 10.1148/radiol.211131. Epub 2022 Mar 29.
Jinho Jung 1, Aiguo Han 1, Egbert Madamba 1, Ricki Bettencourt 1, Rohan R Loomba 1, Andrew S Boehringer 1, Michael P Andre 1, John W Erdman Jr 1, William D O'Brien Jr 1, Kathryn J Fowler 1, Claude B Sirlin 1, Rohit Loomba 1
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 74. | Living in the non-alcoholic fatty liver disease silent epidemic: a qualitative systematic review of patients' perspectives |
| |
Aliment Pharmacol Ther. 2022 Aug;56(4):570-579. doi: 10.1111/apt.17121.Epub 2022 Jul 6.
Cheng Han Ng 1, Wen Hui Lim 1, Yip Han Chin 1, Jie Ning Yong 1, Rebecca Wenling Zeng 1, Kai En Chan 1, Darren Jun Hao Tan 1, Clarissa Elysia Fu 1, Ansel Shao Pin Tang 1, Lay Hoon Goh 2, Kamala Devi 3, Nicholas W S Chew 1 4, Lung-Yi Loey Mak 5, Nobuharu Tamaki 6 7, Daniel Q Huang 1 8 9, Mazen Noureddin 10, Mohammad Shadab Siddiqui 11, Rohit Loomba 6, Arun J Sanyal 11, Mark Muthiah 1 8 9
|
|
| |
|
|
| |
|
|
| |
| 77. | Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study |
| |
Nat Med. 2022 Jul;28(7):1432-1438. doi: 10.1038/s41591-022-01861-9.Epub 2022 Jun 20
Stephen A Harrison 1, Federico Perez Manghi 2, William B Smith 3, Diana Alpenidze 4, Diego Aizenberg 5, Naomi Klarenbeek 6, Chi-Yi Chen 7, Eli Zuckerman 8, Eric Ravussin 9, Phunchai Charatcharoenwitthaya 10, Pin-Nan Cheng 11, Helena Katchman 12, Samuel Klein 13, Ziv Ben-Ari 14, Anisha E Mendonza 15, Yiming Zhang 16, Miljen Martic 17, Shenglin Ma 15, Sheena Kao 18, Sandra Tanner 17, Alok Pachori 15, Michael K Badman 15, YanLing He 15, Chinweike Ukomadu 15, Eric Sicard 19
|
|
| |
|
|
| |
|
|
| |
| 80. | Important Food Sources of Fructose-Containing Sugars and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Controlled Trials |
| |
Nutrients. 2022 Jul 12;14(14):2846. doi: 10.3390/nu14142846.
Danielle Lee 1 2, Laura Chiavaroli 1 2, Sabrina Ayoub-Charette 1 2, Tauseef A Khan 1 2, Andreea Zurbau 1 2 3, Fei Au-Yeung 1 2 3, Annette Cheung 1 2, Qi Liu 1 2, Xinye Qi 1 2, Amna Ahmed 1 2, Vivian L Choo 1 2 4, Sonia Blanco Mejia 1 2, Vasanti S Malik 1 5, Ahmed El-Sohemy 1, Russell J de Souza 1 2 6 7, Thomas M S Wolever 1 3 8, Lawrence A Leiter 1 2 8 9 10, Cyril W C Kendall 1 2 11, David J A Jenkins 1 2 8 9 10, John L Sievenpiper 1 2 8 9 10
|
|
| |
| 81. | The Association of Metabolic-Associated Fatty Liver Disease with Clinical Outcomes of COVID-19: A Systematic Review and Meta-Analysis |
| |
Kans J Med. 2022 Jul 21;15:241-246. doi: 10.17161/kjm.vol15.16522. eCollection 2022.
Umar Hayat 1, Muhammad Zubair Ashfaq 2, Luke Johnson 1, Ryan Ford 1, Chelsea Wuthnow 1, Kevin Kadado 1, Katia El Jurdi 1, Hayrettin Okut 3, William Ransom Kilgore 1 4, Maha Assi 1 5, Ali A Siddiqui 6
|
|
| |
| 82. | Metabolic Associated Fatty Liver Disease Increases the Risk of Systemic Complications and Mortality. A Meta-Analysis and Systematic Review of 12 620 736 Individuals |
| |
Endocr Pract. 2022 Jul;28(7):667-672. doi: 10.1016/j.eprac.2022.03.016.Epub 2022 Mar 29.
Jingxuan Quek 1, Cheng Han Ng 2, Ansel Shao Pin Tang 1, Nicholas Chew 3, Mark Chan 3, Chin Meng Khoo 4, Chen Poh Wei 1, Yip Han Chin 1, Phoebe Tay 1, Grace Lim 5, Darren Jun Hao Tan 1, Wen Hui Lim 1, Kai En Chan 1, Margaret Teng 6, Eunice Tan 7, Nobuharu Tamaki 8, Daniel Q Huang 7, Mohammad Shadab Siddiqui 9, Dan Yock Young 6, Mazen Noureddin 10, Mark D Muthiah 11
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 90. | American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD) |
| |
Endocr Pract. 2022 May;28(5):528-562. doi: 10.1016/j.eprac.2022.03.010.
Kenneth Cusi 1, Scott Isaacs 2, Diana Barb 3, Rita Basu 4, Sonia Caprio 5, W Timothy Garvey 6, Sangeeta Kashyap 7, Jeffrey I Mechanick 8, Marialena Mouzaki 9, Karl Nadolsky 10, Mary E Rinella 11, Miriam B Vos 12, Zobair Younossi 13
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 96. | Evaluation of nonalcoholic fatty liver disease (NAFLD) in severe obesity using noninvasive tests and imaging techniques |
| |
Obes Rev. 2022 Jun 12. doi: 10.1111/obr.13481. Online ahead of print.
Willy Theel 1 2, Bianca M Boxma-de Klerk 3, Femme Dirksmeier-Harinck 4, Elisabeth F C van Rossum 2 5, Danny A Kanhai 6, Jan Apers 7, Bas M van Dalen 8, Robert J de Knegt 9, Anthony G Holleboom 10, Maarten E Tushuizen 11, Diederick E Grobbee 12 13, Janneke Wiebolt 1 2, Manuel Castro Cabezas 1 5 13
|
|
| |
| 97. | The Role of Macronutrients in the Pathogenesis, Prevention and Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) in the Paediatric Population-A Review |
| |
Life (Basel). 2022 Jun 5;12(6):839. doi: 10.3390/life12060839.
Thomas Pixner 1 2, Nathalie Stummer 2 3, Anna Maria Schneider 2 3, Andreas Lukas 1 2, Karin Gramlinger 1, Valérie Julian 4, David Thivel 5, Katharina Mörwald 2 3, Katharina Maruszczak 2 3, Harald Mangge 6, Julian Gomahr 2 3, Daniel Weghuber 2 3, Dieter Furthner 1 2
|
|
| |
|
|
| |
|
|
| |
| 100. | Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease |
| |
Cureus. 2022 May 30;14(5):e25495. doi: 10.7759/cureus.25495.eCollection 2022 May.
Gashaw Hassen 1 2 3 4, Abhishek Singh 5, Gizeshwork Belete 6, Nidhi Jain 7 8 9, Ivonne De la Hoz 10, Genesis P Camacho-Leon 11 12, Nitsuh K Dargie 13, Keila G Carrera 14, Tadesse Alemu 15, Sharan Jhaveri 16, Nebiyou Solomon 15
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 106. | Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants |
| |
Gastroenterology. 2022 Jul 1;S0016-5085(22)00735-1. doi: 10.1053/j.gastro.2022.06.073.Online ahead of print.
Veeral Ajmera 1, Beom Kyung Kim 2, Kun Yang 3, Abdul M Majzoub 4, Tarek Nayfeh 5, Nobuharu Tamaki 6, Namiki Izumi 7, Atsushi Nakajima 8, Ramazan Idilman 9, Mesut Gumussoy 9, Digdem Kuru Oz 10, Ayse Erden 10, Natalie E Quach 3, Xin Tu 3, Xinlian Zhang 3, Mazen Noureddin 11, Alina M Allen 12, Rohit Loomba 13
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 111. | Reduction of De Novo Lipogenesis Mediates Beneficial Effects of Isoenergetic Diets on Fatty Liver: Mechanistic Insights from the MEDEA Randomized Clinical Trial |
| |
Nutrients. 2022 May 23;14(10):2178. doi: 10.3390/nu14102178.
Giuseppina Costabile 1 2, Giuseppe Della Pepa 1, Dominic Salamone 1, Delia Luongo 3, Daniele Naviglio 4, Valentina Brancato 5, Carlo Cavaliere 5, Marco Salvatore 5, Paola Cipriano 1, Marilena Vitale 1, Alessandra Corrado 1, Angela Albarosa Rivellese 1 2, Giovanni Annuzzi 1 2, Lutgarda Bozzetto 1 2
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 115. | Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease |
| |
JHEP Rep. 2022 Mar 26;4(5):100477. doi: 10.1016/j.jhepr.2022.100477. eCollection 2022 May.
Aidan J McGlinchey 1, Olivier Govaere 2, Dawei Geng 3, Vlad Ratziu 4, Michael Allison 5, Jerome Bousier 6, Salvatore Petta 7, Claudia de Oliviera 8, Elisabetta Bugianesi 9, Jörn M Schattenberg 10, Ann K Daly 2, Tuulia Hyötyläinen 3, Quentin M Anstee 2 11, Matej Orešic 1 12
|
|
| |
|
|
| |
| 117. | Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association |
| |
Arterioscler Thromb Vasc Biol. 2022 Jun;42(6):e168-e185.doi: 10.1161/ATV.0000000000000153. Epub 2022 Apr 14.
P Barton Duell, Francine K Welty, Michael Miller, Alan Chait, Gmerice Hammond, Zahid Ahmad, David E Cohen, Jay D Horton, Gregg S Pressman, Peter P Toth, American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Hypertension; Council on the Kidney in Cardiovascular Disease; Council on Lifestyle and Cardiometabolic Health; and Council on Peripheral Vascular Disease
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 124. | Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group |
| |
Lancet Gastroenterol Hepatol. 2022 Apr 28;S2468-1253(22)00061-9.doi: 10.1016/S2468-1253(22)00061-9. Online ahead of print.
Stuart McPherson 1, Matthew J Armstrong 2, Jeremy F Cobbold 3, Lynsey Corless 4, Quentin M Anstee 5, Richard J Aspinall 6, Stephen T Barclay 7, Paul N Brennan 8, Tessa M Cacciottolo 9, Robert D Goldin 10, Kate Hallsworth 5, Vanessa Hebditch 11, Kathryn Jack 12, Helen Jarvis 13, Jill Johnson 14, Wenhao Li 15, Dina Mansour 16, Mary McCallum 17, Ashis Mukhopadhya 17, Richard Parker 18, Valerie Ross 15, Ian A Rowe 19, Ankur Srivastava 20, Prarthana Thiagarajan 12, Alexandra I Thompson 21, Jeremy Tomlinson 22, Emmanuel A Tsochatzis 23, Andrew Yeoman 24, William Alazawi 15
|
|
| |
|
|
| |
|
|
| |
| 127. | Redefinition of Fatty Liver Disease from NAFLD to MAFLD through the Lens of Drug Development and Regulatory Science |
| |
J Clin Transl Hepatol. 2022 Apr 28;10(2):374-382. doi: 10.14218/JCTH.2021.00408.Epub 2021 Oct 22.
Yasser Fouad 1, Melissa Palmer 2 3, Minjun Chen 4, Arie Regev 5, Rajarshi Banerjee 6, Rob Myers 7, Robert Riccio 8, Richard Torstenson 9, Ramy Younes 10, Puneet S Arora 11, Henrik Landgren 12, Morten A Karsdal 13, Martin Blake 14, David A Shapiro 15, Hans-Juergen Gruss 8, Muhammad Y Sheikh 16, Dina Attia 17, Steven Bollipo 18 19, Alastair D Smith 8, Bradley Freilich 20, Robert G Gish 21, Detlef Schuppan 22 23
|
|
| |
| 128. | A Low Glycemic Index Mediterranean Diet Combined with Aerobic Physical Activity Rearranges the Gut Microbiota Signature in NAFLD Patients |
| |
Nutrients. 2022 Apr 23;14(9):1773. doi: 10.3390/nu14091773.
Francesco Maria Calabrese 1, Vittoria Disciglio 2, Isabella Franco 2, Paolo Sorino 2, Caterina Bonfiglio 2, Antonella Bianco 2, Angelo Campanella 2, Tamara Lippolis 2, Pasqua Letizia Pesole 2, Maurizio Polignano 2, Mirco Vacca 1, Giusy Rita Caponio 2, Gianluigi Giannelli 2, Maria De Angelis 1, Alberto Ruben Osella 2
|
|
| |
| 129. | Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases |
| |
Hepatology. 2022 Jan;75(1):219-228. doi: 10.1002/hep.32163. Epub 2021 Dec 10.
Pere Ginès 1 2 3 4, Laurent Castera 5 6 7, Frank Lammert 8 9 10, Isabel Graupera 1 2 3 4, Miquel Serra-Burriel 11, Alina M Allen 12, Vincent Wai-Sun Wong 13, Phillipp Hartmann 14, Maja Thiele 15, Llorenç Caballeria 16, Robert J de Knegt 17, Ivica Grgurevic 18, Salvador Augustin 3 19 20, Emmanuel A Tsochatzis 21, Jörn M Schattenberg 22, Indra Neil Guha 23, Andrea Martini 24, Rosa M Morillas 3 20 25, Montserrat Garcia-Retortillo 26, Harry J de Koning 27, Núria Fabrellas 2 28, Judit Pich 29, Ann T Ma 1 2 4, M Alba Diaz 30, Dominique Roulot 31, Philip N Newsome 32 33, Michael Manns 8, Patrick S Kamath 12, Aleksander Krag 15, LiverScreen Consortium Investigators
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 134. | Advancing the global public health agenda for NAFLD: a consensus statement |
| |
Nat Rev Gastroenterol Hepatol. 2022 Jan;19(1):60-78.doi: 10.1038/s41575-021-00523-4. Epub 2021 Oct 27.
Jeffrey V Lazarus 1 2, Henry E Mark 3, Quentin M Anstee 4 5, Juan Pablo Arab 6, Rachel L Batterham 7, Laurent Castera 8, Helena Cortez-Pinto 9, Javier Crespo 10, Kenneth Cusi 11, M Ashworth Dirac 12, Sven Francque 13 14, Jacob George 15, Hannes Hagström 16, Terry T-K Huang 17, Mona H Ismail 18, Achim Kautz 19, Shiv Kumar Sarin 20, Rohit Loomba 21 22, Veronica Miller 23, Philip N Newsome 24, Michael Ninburg 25, Ponsiano Ocama 26, Vlad Ratziu 27, Mary Rinella 28, Diana Romero 29, Manuel Romero-Gómez 30, Jörn M Schattenberg 31, Emmanuel A Tsochatzis 32 33, Luca Valenti 34 35, Vincent Wai-Sun Wong 36, Yusuf Yilmaz 37 38, Zobair M Younossi 39, Shira Zelber-Sagi 40 41, NAFLD Consensus Consortium
Collaborators, Affiliations collapse
- NAFLD Consensus Consortium:
Fredrik Åberg, Leon Adams, Maryam Salem Al Khatry, Khalid Al Naamani, Omar Alfaro Murillo, Alina M Allen, Faisal Alnaser, Saleh A Alqahtani, Khalid Alswat, Domenico Alvaro, Raúl J Andrade, Marco Arrese, Yaw Asante Awuku, Motala Ayesha, Oidov Baatarkhuu, Shokhista Bakieva, Rita Basu, Ramon Bataller, Shahinaz Bedri, Emanuele Bosi, Marc Bourliere, Radan Bruha, Elisabetta Bugianesi, Patrizia Burra, Maria Buti, Christopher D Byrne, Jose Luis Calleja, Patrizia Carrieri, Flloyd Carter, Marlen Ivon Castellanos Fernandez, Gabriela Castillo-Lopez, Graciela E Castro-Narro, Henry Lik Yuen Chan, Wah-Kheong Chan, Yoosoo Chang, Massimo Colombo, Kirsten J Coppell, Kathleen Corey, Antonio Craxi, Donna Cryer, Anuradha Dassanayake, Antonieta de Ascenção Soares Martins, Victor de Ledinghen, Stefano DelPrato, Alessandro Demaio, Hailemichael Desalegn, John Dillon, Ajay Duseja, Prabhakaran Dorairaj, Mattias Ekstedt, Mohamed El Kassas, Osama M Elsanousi, Gamal Esmat, Jian-Gao Fan, Nathalie Farpour-Lambert, Robert Flisiak, Yasser Fouad, Michael Fuchs, Rino A Gani, Lynn Gerber, Hasmik Ghazinyan, Liana Gheorghe, George Boon-Bee Goh, Henning Grønbæk, Aghayeva Gulnara, Saeed Hamid, Vanessa Hebditch, Ingrid J Hickman, Samantha L Hocking, Bela Hunyady, Ramazan Idilman, Vasily A Isakov, Mohammad H Jamal, Peter Jepsen, Natacha Jreige Iskandar, Myeong Jun Song, K C Sudhamshu, Satoru Kakizaki, George Kalamitsis, Fasiha Kanwal, Jia-Horng Kao, Lee Kaplan, Takumi Kawaguchi, Yousef Khader, Seung Up Kim, Nicolas Kodjoh, Ger Koek, Kazuhiko Koike, Narcisse Patrice Komas, Marko Korenjak, Marcelo Kugelmas, Asma Labidi, Naomi F Lange, Joel E Lavine, Mariana Lazo, Nancy Lee, Cosmas Rinaldi A Lesmana, Chun-Jen Liu, Michelle T Long, Patricio Lopez-Jaramillo, Reza Malekzadeh, Mamun Al Mahtab, Giulio Marchesini, Rui Marinho, Sophia E Martínez Vázquez, Lyudmila Mateva, Charles Mbendi Nlombi, Pascal Melin, Ivana Mikolasevic, Tamara Milovanovic, Carla Musso, Atsushi Nakajima, Edna Nava, Alexander V Nersesov, Dafina Nikolova, Suzanne Norris, Katja Novak, Jude Oben, Janus P Ong, Charles Onyekwere, George Papatheodoridis, Imran Paruk, Keyur Patel, M Paula Macedo, Carlos Penha-Gonçalves, Marlene Pérez Figueroa, Wolf Peter Hofmann, Salvatore Petta, Claudia Pinto Marques Souza de Oliveira, Puneet Puri, Calvin Q Pan, Marek Rac, Johanna Ralston, Alnoor Ramji, Homie Razavi, Mario Reis Alvares-da-Silva, Stuart Roberts, Michael Roden, Tamsin Rose, Samir Rouabhia, Patrizia Rovere-Querini, Ian A Rowe, Shakhlo Sadirova, Riina Salupere, Tobokalova Saparbu, Raymond Sayegh, Giada Sebastiani, Yosuke Seki, Josefina Selmo,
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 142. | Inhibition of 11ß-Hydroxysteroid dehydrogenase-1 with AZD4017 in patients with nonalcoholic steatohepatitis or nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, phase II study |
| |
Diabetes Obes Metab. 2022 May;24(5):881-890.doi: 10.1111/dom.14646.Epub 2022 Jan 25.
Yogesh Yadav 1, Kelly Dunagan 2, Rachita Khot 3, Sudhakar K Venkatesh 2, John Port 2, Alfonso Galderisi 4, Claudio Cobelli 4, Craig Wegner 5, Ananda Basu 1, Rickey Carter 6, Rita Basu 1
|
|
| |
|
|
| |
|
|
| |
| 145. | Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis |
| |
Gut. 2022 May;71(5):1006-1019. doi: 10.1136/gutjnl-2021-324243.Epub 2021 May 17.
Ferenc Emil Mózes 1, Jenny A Lee 2, Emmanuel Anandraj Selvaraj 1 3 4, Arjun Narayan Ajmer Jayaswal 1, Michael Trauner 5, Jerome Boursier 6 7, Céline Fournier 8, Katharina Staufer 5 9 10, Rudolf E Stauber 11, Elisabetta Bugianesi 12, Ramy Younes 13, Silvia Gaia 12, Monica Lup?or-Platon 14, Salvatore Petta 15, Toshihide Shima 16, Takeshi Okanoue 16, Sanjiv Mahadeva 17, Wah-Kheong Chan 17, Peter J Eddowes 18 19, Gideon M Hirschfield 20, Philip Noel Newsome 18 21 22, Vincent Wai-Sun Wong 23, Victor de Ledinghen 24 25, Jiangao Fan 26, Feng Shen 26, Jeremy F Cobbold 3 4, Yoshio Sumida 27, Akira Okajima 28, Jörn M Schattenberg 29, Christian Labenz 29, Won Kim 30, Myoung Seok Lee 31, Johannes Wiegand 32, Thomas Karlas 32, Yusuf Yilmaz 33 34, Guruprasad Padur Aithal 19 35, Naaventhan Palaniyappan 19 35, Christophe Cassinotto 36, Sandeep Aggarwal 37, Harshit Garg 37, Geraldine J Ooi 38, Atsushi Nakajima 39, Masato Yoneda 39, Marianne Ziol 40, Nathalie Barget 41, Andreas Geier 42, Theresa Tuthill 43, M Julia Brosnan 43, Quentin Mark Anstee 44, Stefan Neubauer 1, Stephen A Harrison 1, Patrick M Bossuyt 2, Michael Pavlides 45 3 4, LITMUS Investigators
|
|
| |
|
|
| |
| 147. | Effects of exercise on NAFLD using non-targeted metabolomics in adipose tissue, plasma, urine, and stool |
| |
Sci Rep. 2022 Apr 20;12(1):6485.doi: 10.1038/s41598-022-10481-9.
Ambrin Farizah Babu # 1 2, Susanne Csader # 1, Ville Männistö 3, Milla-Maria Tauriainen 1 3, Heikki Pentikäinen 4, Kai Savonen 4 5, Anton Klåvus 2, Ville Koistinen 1 2 6, Kati Hanhineva 1 2 6, Ursula Schwab 7 8
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 155. | Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease |
| |
Gastroenterology. 2021 Nov;161(5):1657-1669. doi: 10.1053/j.gastro.2021.07.049.Epub 2021 Sep 20.
Fasiha Kanwal 1, Jay H Shubrook 2, Leon A Adams 3, Kim Pfotenhauer 4, Vincent Wai-Sun Wong 5, Eugene Wright 6, Manal F Abdelmalek 6, Stephen A Harrison 7, Rohit Loomba 8, Christos S Mantzoros 9, Elisabetta Bugianesi 10, Robert H Eckel 11, Lee M Kaplan 12, Hashem B El-Serag 1, Kenneth Cusi 13
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 160. | Validation of the accuracy of the FAST™ score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithms |
| |
PLoS One. 2022 Apr 15;17(4):e0266859.doi: 10.1371/journal.pone.0266859. eCollection 2022.
Tinsay A Woreta 1, Mark L Van Natta 2, Mariana Lazo 3, Arunkumar Krishnan 1, Brent A Neuschwander-Tetri 4, Rohit Loomba 5, Anna Mae Diehl 6, Manal F Abdelmalek 6, Naga Chalasani 7, Samer Gawrieh 7, Srinivasan Dasarathy 8, Raj Vuppalanchi 7, Mohammad S Siddiqui 9, Kris V Kowdley 10, Arthur McCullough 8, Norah A Terrault 11, Cynthia Behling 5, David E Kleiner 12, Mark Fishbein 13, Paula Hertel 14, Laura A Wilson 2, Emily P Mitchell 2, Laura A Miriel 2, Jeanne M Clark 1, James Tonascia 2, Arun J Sanyal 9, NASH Clinical Research Network
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 164. | The Effect of High-intensity Interval Training vs Moderate-intensity Continuous Training on Liver Fat: A Systematic Review and Meta-Analysis |
| |
J Clin Endocrinol Metab. 2022 Feb 17;107(3):862-881.doi: 10.1210/clinem/dgab795.
Angelo Sabag 1 2, Loren Barr 2, Mike Armour 1 3, Alex Armstrong 4, Callum J Baker 5, Stephen M Twigg 5 6, Dennis Chang 1, Daniel A Hackett 4, Shelley E Keating 7, Jacob George 8, Nathan A Johnson 4 9
|
|
| |
| 165. | Genome-Wide Association Study of NAFLD Using Electronic Health Records |
| |
Hepatol Commun. 2022 Feb;6(2):297-308. doi: 10.1002/hep4.1805.Epub 2021 Sep 17.
Cameron J Fairfield 1, Thomas M Drake 1, Riinu Pius 1, Andrew D Bretherick 2, Archie Campbell 1 3 4, David W Clark 5, Jonathan A Fallowfield 6, Caroline Hayward 2, Neil C Henderson 6, Peter K Joshi 5, Nicholas L Mills 7, David J Porteous 3, Prakash Ramachandran 6, Robert K Semple 7, Catherine A Shaw 1, Cathie L M Sudlow 1, Paul R H J Timmers 2 5, James F Wilson 2 5, Stephen J Wigmore 8, Ewen M Harrison # 1 8, Athina Spiliopoulou # 5
|
|
| |
|
|
| |
|
|
| |
| 168. | A sustainable development goal framework to guide multisectoral action on NAFLD through a societal approach |
| |
Aliment Pharmacol Ther. 2022 Jan;55(2):234-243. doi: 10.1111/apt.16720. Epub 2021 Dec 5.
Jeffrey V Lazarus 1 2, Henry E Mark 2, Massimo Colombo 2 3, Sandro Demaio 4, John F Dillon 5, Jacob George 6, Hannes Hagström 7, Samantha Hocking 6, Nancy Lee 8, Mark J Nieuwenhuijsen 1, Mary E Rinella 9, Manuel Romero-Gomez 10, Joan B Soriano 11, Jörn M Schattenberg 12, Frank Tacke 13, Emmanuel A Tsochatzis 14, Luca Valenti 3, Shira Zelber-Sagi 15 16, M Ashworth Dirac 17, Terry T-K Huang 18
|
|
| |
|
|
| |
| 170. | Variation in Alanine Aminotransferase in Children with Non-Alcoholic Fatty Liver Disease |
| |
Children (Basel). 2022 Mar 8;9(3):374. doi: 10.3390/children9030374.
Eduardo Castillo-Leon 1 2, Heather L Morris 3, Cheryl Schoen 3, Jacob Bilhartz 4, Patrick McKiernan 5, Tamir Miloh 6, Sirish Palle 7, Mohammad Nasser Kabbany 8, Breda Munoz 3, Andrea R Mospan 3, Bryan Rudolph 9, Stavra A Xanthakos 10, Miriam B Vos 11, Target-Nash Investigators
|
|
| |
| 171. | Randomised clinical trial: A phase 2 double-blind study of namodenoson in non-alcoholic fatty liver disease and steatohepatitis |
| |
Aliment Pharmacol Ther. 2021 Dec;54(11-12):1405-1415. doi: 10.1111/apt.16664.Epub 2021 Oct 20.
Rifaat Safadi 1, Marius Braun 2, Adi Francis 3, Yael Milgrom 1, Muhammad Massarwa 1, David Hakimian 1, Wadi Hazou 1, Assaf Issachar 2, Zivit Harpaz 4, Motti Farbstein 4, Inbal Itzhak 4, Naama Lev-Cohain 5, Avital Bareket-Samish 6, Michael H Silverman 4, Pnina Fishman 4
|
|
| |
| 172. | Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis |
| |
Hepatology. 2022 May;75(5):1235-1246. doi: 10.1002/hep.32204. Epub 2022 Feb 7.
Arun J Sanyal 1, Quentin M Anstee 2, Michael Trauner 3, Eric J Lawitz 4, Manal F Abdelmalek 5 6, Dora Ding 7, Ling Han 7, Catherine Jia 7, Ryan S Huss 7, Chuhan Chung 7, Vincent Wai-Sun Wong 8, Takeshi Okanoue 9, Manuel Romero-Gomez 10, Andrew J Muir 5 6, Nezam H Afdhal 11, Jaime Bosch 12 13, Zachary Goodman 14, Stephen A Harrison 15, Zobair M Younossi 14, Robert P Myers 7
|
|
| |
|
|
| |
| 174. | Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease |
| |
Am J Gastroenterol. 2021 Dec 1;116(12):2399-2409.doi: 10.14309/ajg.0000000000001375.
Stephen A Harrison 1, Seth J Baum 2, Nadege T Gunn 3, Ziad H Younes 4, Anita Kohli 5, Rashmee Patil 6, Margaret J Koziel 7, Harinder Chera 7, Jeff Zhao 7, Manu V Chakravarthy 7
|
|
| |
|
|
| |
|
|
| |
| 177. | Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH Study |
| |
Clin Gastroenterol Hepatol. 2022 Feb;20(2):458-460.e4. doi: 10.1016/j.cgh.2021.03.031.Epub 2021 Mar 26.
Mary J Thomson 1, Marina Serper 2, Vandana Khungar 2, L Michael Weiss 3, Huy Trinh 4, Roberto Firpi-Morell 5, Michael Roden 6, Rohit Loomba 7, A Sidney Barritt 4th 8, Derek Gazis 9, Andrea R Mospan 9, Michael W Fried 9, K Rajender Reddy 2, Anna S Lok 10
|
|
| |
| 178. | The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge? |
| |
J Hepatol. 2022 Apr;76(4):771-780. doi: 10.1016/j.jhep.2021.10.025. Epub 2021 Dec 9.
Jeffrey V Lazarus 1, Henry E Mark 2, Marcela Villota-Rivas 3, Adam Palayew 4, Patrizia Carrieri 5, Massimo Colombo 6, Mattias Ekstedt 7, Gamal Esmat 8, Jacob George 9, Giulio Marchesini 10, Katja Novak 11, Ponsiano Ocama 12, Vlad Ratziu 13, Homie Razavi 14, Manuel Romero-Gómez 15, Marcelo Silva 16, C Wendy Spearman 17, Frank Tacke 18, Emmanuel A Tsochatzis 19, Yusuf Yilmaz 20, Zobair M Younossi 21, Vincent W-S Wong 22, Shira Zelber-Sagi 23,
Helena Cortez-Pinto 24, Quentin M Anstee 25, NAFLD policy review collaborators
Collaborators
- NAFLD policy review collaborators:
Samir Rouabhia
26
, Hasmik Ghazinyan
27,
Natacha Jreige Iskandar
28, Michael Trauner
29,
Gulnara Aghayeva
30, Flloyd Carter
31, Kannan Sridharan
32, Mamun Al Mahtab
33, Sven Francque
34, Nicolas Kodjoh
35,
Ruben Muñoz Camacho
36, Motswedi Anderson
37,
Claudia Pinto Marques Souza de Oliveira
38,
Lyudmila Mateva
39, Abdel Karim Serme
40,
Antonieta A Soares Martins
41,
Mark G Swain
42,
Narcisse Patrice Komas
43, Ming-Hua Zheng
44, Patricio Lopez Jaramillo
45, Omar Alfaro Murillo
46,
Ivana Mikolasevic
47, Emmelia Vounou
48, Radan Bruha
49, Charles Mbendi Nlombi
50, Maja Thiele
51, Marlene Perez
52, Juan José
Suárez M
53,
Imam Waked
54, Riina Salupere
55, Hailemichael Desalegn
56, Hannele Yki-Järvinen 57, Tengiz Tsertsvadze 58, Lali Sharvadze 58, Maia Butsashvili 58, Yaw Asante Awuku 59, Georgios Papatheodoridis 60, Bela Hunyady 61, Einar Stefan Bjornsson 62, Ajay Duseja 63, Cosmas Rinaldi A Lesmana 64, Reza Malekzadeh 65, Suzanne Norris 66, Kazuhiko Koike 67, Alexander V Nersesov 68, Missiani Ochwoto 69, Mohammad Jamal 70, Tobokalova Saparbu 71, Ieva Tolmane 72, Raymond Sayegh 73, Dhastagir Sultan Sheriff 74, Jonas Valantinas 75, Joseph Weber 76, Isaac Thom Shawa 77, Soek-Siam Tan 78, Sophia E Martínez Vázquez 79, Oidov Baatarkhuu 80, Undram Lkhagvaa 80, Tsolmon Jadamba 80, Tahiri Mohammed 81, K C Sudhamshu 82, Kirsten Coppell 83
, Charles Onyekwere 84,&nbs |
|
| |
| 179. | Efficacy and safety of an orally administered DGAT2 inhibitor alone or coadministered with a liver-targeted ACC inhibitor in adults with non-alcoholic steatohepatitis (NASH): rationale and design of the phase II, dose-ranging, dose-finding, randomised, placebo-controlled MIRNA (Metabolic Interventions to Resolve NASH with fibrosis) study |
| |
BMJ Open. 2022 Mar 30;12(3):e056159. doi: 10.1136/bmjopen-2021-056159.
Neeta B Amin 1, Amanda Darekar 2, Quentin M Anstee 3, Vincent Wai-Sun Wong 4, Frank Tacke 5, Manoli Vourvahis 6, Douglas S Lee 7, Michael Charlton 8, Naim Alkhouri 9, Atsushi Nakajima 10, Carla Yunis 6
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 183. | Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity score |
| |
Hepatology. 2022 Mar 25. doi: 10.1002/hep.32475. Online ahead of print.
Rish K Pai 1, Vipul Jairath 2 3 4, Malcolm Hogan 3, Guangyong Zou 3 4 5, Oyedele A Adeyi 6, Quentin M Anstee 7 8, Bashar A Aqel 9, Cynthia Behling 10 11, Elizabeth J Carey 9, Andrew D Clouston 12, Kathleen Corey 13 14, Brian G Feagan 2 3 4, David E Kleiner 15, Christopher Ma 3 16 17, Stefanie C McFarlane 3, Mazen Noureddin 18, Vlad Ratziu 19, Mark A Valasek 20, Zobair M Younossi 21 22, Stephen A Harrison 23 24, Rohit Loomba 25
|
|
| |
|
|
| |
| 185. | Bariatric Surgery in NAFLD |
| |
Dig Dis Sci. 2022 Feb;67(2):408-422. doi: 10.1007/s10620-021-07317-3.Epub 2022 Jan 4.
Mahak Chauhan 1, Kuldeep Singh 1, Paul J Thuluvath 2 3
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 191. | Point Shear Wave Elastography by ElastPQ for Fibrosis Screening in Patients with NAFLD: A Prospective, Multicenter Comparison to Vibration-Controlled Elastography |
| |
Ultraschall Med. 2022 Feb 28. doi: 10.1055/a-1724-7289. Online ahead of print.
David Jm Bauer 1 2, Vladimir Matic 3, Ruxandra Mare 4, Laura Maiocchi 5, David Chromy 1 2, Theresa Müllner-Bucsics 1 2, Mattias Mandorfer 1 2, Sandra Mustapic 3, Ioan Sporea 6, Giovanna Ferraioli 5, Ivica Grgurevic 3, Thomas Reiberger 1 2 7
|
|
| |
|
|
| |
| 193. | Aldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3): a randomised, double-blind, placebo-controlled, phase 2b trial |
| |
Lancet Gastroenterol Hepatol. 2022 Mar 21;S2468-1253(22)00017-6.doi: 10.1016/S2468-1253(22)00017-6. Online ahead of print.
Stephen A Harrison 1, Manal F Abdelmalek 2, Guy Neff 3, Nadege Gunn 4, Cynthia D Guy 5, Naim Alkhouri 6, Mustafa R Bashir 7, Bradley Freilich 8, Anita Kohli 9, Arun Khazanchi 10, Muhammad Y Sheikh 11, Mark Leibowitz 12, Mary E Rinella 13, Mohammad S Siddiqui 14, Mark Kipnes 15, Sam E Moussa 16, Ziad H Younes 17, Meena Bansal 18, Seth J Baum 19, Brian Borg 20, Peter J Ruane 21, Paul J Thuluvath 22, Mildred Gottwald 23, Mujib Khan 23, Charles Chen 23, Liza Melchor-Khan 23, William Chang 23, Alex M DePaoli 23, Lei Ling 24, Hsiao D Lieu 23
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 197. | The fecal mycobiome in non-alcoholic fatty liver disease |
| |
J Hepatol. 2022 Apr;76(4):788-799. doi: 10.1016/j.jhep.2021.11.029. Epub 2021 Dec 10.
Münevver Demir 1, Sonja Lang 2, Phillipp Hartmann 3, Yi Duan 4, Anna Martin 5, Yukiko Miyamoto 4, Marina Bondareva 6, Xinlian Zhang 7, Yanhan Wang 4, Philipp Kasper 5, Corinna Bang 8, Christoph Roderburg 9, Frank Tacke 1, Hans-Michael Steffen 5, Tobias Goeser 5, Andrey Kruglov 6, Lars Eckmann 4, Peter Stärkel 10, Derrick E Fouts 11, Bernd Schnabl 12
|
|
| |
| 198. | Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? |
| |
Gut. 2022 Feb;71(2):382-390. doi: 10.1136/gutjnl-2020-322564. Epub 2021 Feb 4.
Ramy Younes 1 2 3, Olivier Govaere 1, Salvatore Petta 4, Luca Miele 5 6, Dina Tiniakos 1 7, Alastair Burt 1, Ezio David 3, Fabio Maria Vecchio 5 8, Marco Maggioni 9, Daniela Cabibi 10, Duncan McLeod 11, Maria Jesus Pareja 12, Anna Ludovica Fracanzani 13, Rocio Aller 14, Chiara Rosso 3, Javier Ampuero 15, Rocío Gallego-Durán 15, Angelo Armandi 3, Gian Paolo Caviglia 3, Marco Y W Zaki 1 16, Antonio Liguori 5, Paolo Francione 13, Grazia Pennisi 4, Antonio Grieco 5 6, Giovanni Birolo 3, Piero Fariselli 3, Mohammed Eslam 17, Luca Valenti 18, Jacob George 17, Manuel Romero-Gómez 15, Quentin Mark Anstee 19 20, Elisabetta Bugianesi 21
|
|
| |
| 199. | Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease |
| |
J Clin Invest. 2021 Dec 15;131(24):e150996. doi: 10.1172/JCI150996.
Catherine C Cohen 1 2, Kelvin W Li 3, Adina L Alazraki 4 5, Carine Beysen 6, Carissa A Carrier 7, Rebecca L Cleeton 1, Mohamad Dandan 3, Janet Figueroa 1, Jack Knight-Scott 5, Cynthia J Knott 8, Kimberly P Newton 7 9, Edna M Nyangau 3, Claude B Sirlin 10, Patricia A Ugalde-Nicalo 7 9, Jean A Welsh 1 11, Marc K Hellerstein 3, Jeffrey B Schwimmer 7 9, Miriam B Vos 1 11
|
|
| |
| 200. | Deep proteomic profiling unveils arylsulfatase A as a non-alcoholic steatohepatitis inducible hepatokine and regulator of glycemic control |
| |
Nat Commun. 2022 Mar 10;13(1):1259. doi: 10.1038/s41467-022-28889-2.
Magdalene K Montgomery 1, Jacqueline Bayliss 2, Shuai Nie 3, William De Nardo 2, Stacey N Keenan 2, Paula M Miotto 2, Hamzeh Karimkhanloo 2 4, Cheng Huang 5, Ralf B Schittenhelm 5, Anthony S Don 6, Andrew Ryan 7, Nicholas A Williamson 3, Geraldine J Ooi 8, Wendy A Brown 8, Paul R Burton 8, Benjamin L Parker 2, Matthew J Watt 9
|
|
| |
|
|
| |
|
|
| |
| 203. | Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD |
| |
J Hepatol. 2022 Jan 25;S0168-8278(22)00024-1. doi: 10.1016/j.jhep.2022.01.011.Online ahead of print.
Elizabeth M Brunt 1, Andrew D Clouston 2, Zachary Goodman 3, Cynthia Guy 4, David E Kleiner 5, Carolin Lackner 6, Dina G Tiniakos 7, Aileen Wee 8, Matthew Yeh 9, Wei Qiang Leow 10, Elaine Chng 11, Yayun Ren 11, George Goh Boon Bee 12, Elizabeth E Powell 13, Mary Rinella 14, Arun J Sanyal 15, Brent Neuschwander-Tetri 16, Zobair Younossi 17, Michael Charlton 18, Vlad Ratziu 19, Stephen A Harrison 20, Dean Tai 21, Quentin M Anstee 22
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 209. | Interactions of physical activity, muscular fitness, adiposity, and genetic risk for NAFLD |
| |
Hepatol Commun. 2022 Mar 15. doi: 10.1002/hep4.1932. Online ahead of print.
Theresia M Schnurr 1 2, Sophia Figueroa Katz 1 3, Johanne M Justesen 1 2, Jack W O'Sullivan 1, Peter Saliba-Gustafsson 1 4, Themistocles L Assimes 1 5, Ivan Carcamo-Orive 1 6, Aijaz Ahmed 7, Euan A Ashley 1 8 9, Torben Hansen 2, Joshua W Knowles 1 6 10
|
|
| |
| 210. | Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD) |
| |
Aliment Pharmacol Ther. 2022 Mar 17. doi: 10.1111/apt.16874. Online ahead of print.
Danielle Brandman 1, Marie Boyle 2 3, Stuart McPherson 2 3, Mark L Van Natta 4, Arun J Sanyal 5, Kris Kowdley 6, Brent Neuschwander-Tetri 7, Naga Chalasani 8, Manal F Abdelmalek 9, Norah A Terrault 10, Art McCullough 11, Ricki Bettencourt 12, Cyrielle Caussy 12, David E Kleiner 13, Cynthia Behling 14, James Tonascia 4, Quentin M Anstee 2, Rohit Loomba 12, Members of the Nonalcoholic Steatohepatitis Clinical Research Network
|
|
| |
|
|
| |
|
| | | | | |
